TMEM97 and renal carcinoma: Interestingly, σ2R/TMEM97 was found to be downregulated in other cancers, such as meningiomas, pancreatic, and renal cancers, suggesting that it may have a complex and cancer-cell-type-dependent role in cancer development [61].